Studies have shown that LACTB plays an important role in inhibiting liver cancer (50), breast cancer (51), bladder cancer (48), and colorectal cancer (52), and downregulation of LACTB expression often indicates poor prognosis. Here, LACTB is linked to breast carcinoma.